About Prokidney Corp
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://prokidney.com/
Frequently Asked Questions
What is the 52-week range for PROK?
The 52-week high is $3.4799 and the 52-week low is $1.3.
What is the P/E ratio for PROK?
The P/E ratio data is currently unavailable.
What is the dividend yield for PROK?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -28.10%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -10288.39%.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Analyst Recommendation Trends
Wall Street analyst consensus for PROK over the last few months:
Latest PROK News
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
Seven abstracts spanning CKD translational model studies and drug product characterization provide converging evidence supporting a multifactorial mechanism of action for rilparencelOne clinical abstract presents a new pooled Phase 2 analysis of patients meeting key PROACT 1 inclusion criteria that continues to indicate a strong safety profile and kidney function stabilization in patients with advanced CKD and type 2 diabetes mellitus WINSTON-SALEM, N.C., Oct. 02, 2026 (GLOBE NEWSWIRE) -- ProKid
ProKidney (PROK) Nears A Pivotal Kidney Therapy Verdict
On August 10, ProKidney Corp. (NASDAQ:PROK) reported second-quarter financial results that doubled as a status update on the biggest bet in its history: a cell therapy for chronic kidney disease that is now one step closer to a verdict. The clinical-stage company completed enrollment for the analysis that will decide whether its treatment gets an […]
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-20 | Pereira Brian JG | -27,052 | $1.4199 | $38,411 |
| 2026-08-20 | Pereira Brian JG | -222,948 | $1.4199 | $316,564 |
| 2026-08-19 | Pereira Brian JG | -27,051 | $1.4407 | $38,972 |
| 2026-08-19 | Pereira Brian JG | -222,949 | $1.4407 | $321,203 |
| 2026-08-18 | Pereira Brian JG | -27,826 | $1.3712 | $38,155 |
| 2026-08-18 | Pereira Brian JG | -229,338 | $1.3712 | $314,468 |
| 2026-08-04 | Pereira Brian JG | -675,235 | - | - |
| 2026-08-04 | Pereira Brian JG | -675,235 | - | - |
| 2026-08-04 | Pereira Brian JG | -81,929 | - | - |
| 2026-08-04 | Pereira Brian JG | -81,929 | - | - |
| 2026-08-04 | Pereira Brian JG | +675,235 | - | - |
| 2026-08-04 | Pereira Brian JG | +81,929 | - | - |
| 2026-07-01 | Locke Kenneth Thomas | +750,000 | - | - |
| 2026-06-12 | Girolamo Todd C | -163,857 | - | - |
| 2026-06-12 | Girolamo Todd C | -163,857 | - | - |
| 2026-06-12 | Girolamo Todd C | +163,857 | - | - |
| 2026-05-28 | Jimenez Santos Jose Ignacio | +135,000 | - | - |
| 2026-05-28 | Fox Jennifer A. | +135,000 | - | - |
| 2026-05-28 | Sinha Uma | +135,000 | - | - |
| 2026-05-28 | Legorreta Pablo G. | +135,000 | - | - |
| 2026-05-28 | Lotvin Alan | +135,000 | - | - |
| 2026-05-28 | Pereira Brian JG | +135,000 | - | - |
| 2026-05-28 | DOYLE WILLIAM F | +135,000 | - | - |
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. | -63,118,645 | - | - |
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. | -63,118,645 | - | - |
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. | +63,118,645 | - | - |
| 2026-03-01 | Coulston James | +600,000 | - | - |
| 2026-03-01 | Weber Darin J. | +400,000 | - | - |
| 2026-03-01 | Girolamo Todd C | +600,000 | - | - |
| 2026-03-01 | Culleton Bruce | +3,000,000 | - | - |
| 2025-11-13 | Pereira Brian JG | -54,333 | $2.37 | $128,769 |
| 2025-11-13 | Pereira Brian JG | -447,803 | $2.37 | $1,061,293 |
| 2025-11-12 | Pereira Brian JG | -27,595 | $2.7234 | $75,152 |
| 2025-11-12 | Pereira Brian JG | -227,431 | $2.7233 | $619,363 |